Abstract
Objective:
To evaluate placental gene expression in severe early- or late-onset preeclampsia with intrauterine growth restriction compared to controls.
Study design:
Chorionic villus sampling was conducted after cesarean section from the placentas of five women with early- or late-onset severe preeclampsia and five controls for each preeclampsia group. Microarray analysis was performed to identify gene expression differences between the groups.
Results:
Pathway analysis showed over-representation of gene ontology (GO) biological process terms related to inflammatory and immune response pathways, platelet development, vascular development, female pregnancy and reproduction in early-onset preeclampsia. Pathways related to immunity, complement and coagulation cascade were overrepresented in the hypergeometric test for the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. Ten genes (ABI3BP, C7, HLA-G, IL2RB, KRBOX1, LRRC15, METTL7B, MPP5, RFLNB and SLC20A) had a ≥±1 fold expression difference in severe early-onset preeclampsia group compared to early controls. There were 362 genes that had a ≥±1 fold expression difference in severe early-onset preeclampsia group compared to late-onset preeclampsia group including ABI3BP, C7, HLA-G and IL2RB.
Conclusion:
There are significant differences in placental gene expression between severe early- and late-onset preeclampsia when both are associated with intrauterine growth restriction. ABI3BP, C7, HLA-G and IL2RB might contribute to the development of early form of severe preeclampsia.
Author’s statement
Conflict of interest: Authors state no conflict of interest.
Material and methods: Informed consent: Informed consent has been obtained from all individuals included in this study.
Ethical approval: The research related to human subject use has complied with all the relevant national regulations, and institutional policies, and is in accordance with the tenets of the Helsinki Declaration, and has been approved by the authors’ institutional review board or equivalent committee.
Funding: The Finnish Society of Obstetrics and Gynaecology.
References
[1] Airoldi J, Weinstein L. Clinical significance of proteinuria in pregnancy. Obstet Gynecol Surv. 2007;62:117–24.10.1097/01.ogx.0000253301.55009.acSearch in Google Scholar PubMed
[2] Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011;7:467–74.10.2147/VHRM.S20181Search in Google Scholar PubMed PubMed Central
[3] Bokslag A, van Weissenbruch M, Mol BW, de Groot CJ. Preeclampsia; short and long-term consequences for mother and neonate. Early Hum Dev. 2016;102:47–50.10.1016/j.earlhumdev.2016.09.007Search in Google Scholar PubMed
[4] Warrington JP, George EM, Palei AC, Spradley FT, Granger JP. Recent advances in the understanding of the pathophysiology of preeclampsia. Hypertension. 2013;62:666–73.10.1161/HYPERTENSIONAHA.113.00588Search in Google Scholar PubMed PubMed Central
[5] Borrego-Díaz E, Rosales JC, Proverbio T, Teppa-Garrán A, Andaluz R, Abad C, et al. Effect of placental hypoxia on the plasma membrane Ca-ATPase (PMCA) activity and the level of lipid peroxidation of syncytiotrophoblast and red blood cell ghosts. Placenta. 2008;29:44–50.10.1016/j.placenta.2007.08.006Search in Google Scholar PubMed
[6] Yliniemi A, Nurkkala MM, Kopman S, Korpimaki T, Kouru H, Ryynanen M, et al. First trimester placental retinol-binding protein 4 (RBP4) and pregnancy-associated placental protein A (PAPP-A) in the prediction of early-onset severe pre-eclampsia. Metabolism. 2015;64:521–6.10.1016/j.metabol.2014.12.008Search in Google Scholar PubMed
[7] Yliniemi A, Makikallio K, Korpimaki T, Kouru H, Marttala J, Ryynanen M. Combination of PAPPA, fhCGβ, AFP, PlGF, sTNFR1, and maternal characteristics in prediction of early-onset preeclampsia. Clin Med Insights Reprod Health. 2015;9:13–20.10.4137/CMRH.S21865Search in Google Scholar PubMed PubMed Central
[8] Leavey K, Benton SJ, Grynspan D, Kingdom JC, Bainbridge SA, Cox BJ. Unsupervised placental gene expression profiling identifies clinically relevant subclasses of human preeclampsia. Hypertension. 2016;68:137–47.10.1161/HYPERTENSIONAHA.116.07293Search in Google Scholar PubMed
[9] Farag K, Hassan I, Ledger WL. Prediction of preeclampsia: can it be achieved? Obstet Gynecol Surv. 2004;59:464–82.10.1097/00006254-200406000-00025Search in Google Scholar PubMed
[10] Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216:110–20.10.1016/j.ajog.2016.09.076Search in Google Scholar PubMed
[11] Browne JL, Klipstein-Grobusch K, Franx A, Grobbee DE. Prevention of hypertensive disorders of pregnancy: a novel application of the polypill concept. Curr Cardiol Rep. 2016;18:59.10.1007/s11886-016-0725-xSearch in Google Scholar PubMed
[12] Reimer T, Koczan D, Gerber B, Richter D, Thiesen HJ, Friese K. Microarray analysis of differentially expressed genes in placental tissue of pre-eclampsia: up-regulation of obesity-related genes. Mol Hum Reprod. 2002;8:674–80.10.1093/molehr/8.7.674Search in Google Scholar PubMed
[13] Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649–58.10.1172/JCI17189Search in Google Scholar PubMed
[14] Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12:642–9.10.1038/nm1429Search in Google Scholar PubMed
[15] van Uitert M, Moerland PD, Enquobahrie DA, Laivuori H, van der Post JA, Ris-Stalpers C, et al. Meta-analysis of placental transcriptome data identifies a novel molecular pathway related to preeclampsia. PLoS One. 2015;10:e0132468.10.1371/journal.pone.0132468Search in Google Scholar PubMed
[16] ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2002;99:159–67.10.1016/S0029-7844(01)01747-1Search in Google Scholar PubMed
[17] Kallio MA, Tuimala JT, Hupponen T, Klemelä P, Gentile M, Scheinin I, et al. Chipster: user-friendly analysis software for microarray and other high-throughput data. BMC Genomics. 2011;12:507.10.1186/1471-2164-12-507Search in Google Scholar PubMed PubMed Central
[18] Ichigotani Y, Fujii K, Hamaguchi M, Matsuda S. In search of a function for the E3B1/Abi2/Argbp1/NESH family (Review). Int J Mol Med. 2002;9:591–5.10.3892/ijmm.9.6.591Search in Google Scholar PubMed
[19] Latini FR, Hemerly JP, Freitas BC, Oler G, Riggins GJ, Cerutti JM. ABI3 ectopic expression reduces in vitro and in vivo cell growth properties while inducing senescence. BMC Cancer. 2011;11:11.10.1186/1471-2407-11-11Search in Google Scholar PubMed PubMed Central
[20] Regal JF, Gilbert JS, Burwick RM. The complement system and adverse pregnancy outcomes. Mol Immunol. 2015;67:56–70.10.1016/j.molimm.2015.02.030Search in Google Scholar PubMed PubMed Central
[21] Bulla R, Bossi F, Tedesco F. The complement system at the embryo implantation site: friend or foe? Front Immunol. 2012;3:55.10.3389/fimmu.2012.00055Search in Google Scholar PubMed
[22] Moreau P, Contu L, Alba F, Lai S, Simoes R, Orrù S, et al. HLA-G gene polymorphism in human placentas: possible association of G*0106 allele with preeclampsia and miscarriage. Biol Reprod. 2008;79:459–67.10.1095/biolreprod.108.068874Search in Google Scholar PubMed
[23] Le Rond S, Le Maoult J, Créput C, Menier C, Deschamps M, Le Friec G, et al. Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients. Eur Immunol. 2004;34:649–60.10.1002/eji.200324266Search in Google Scholar
[24] Glas J, Török HP, Tonenchi L, Wetzke M, Beynon V, Teshome MY, et al. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn’s disease and is associated with ileocecal resection in Crohn’s disease. Int Immunol. 2007;19:621–6.10.1093/intimm/dxm027Search in Google Scholar PubMed
[25] Ugurel S, Rebmann V, Ferrone S, Tilgen W, Grosse-Wilde H, Reinhold U. Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Cancer. 2001;92:369–76.10.1002/1097-0142(20010715)92:2<369::AID-CNCR1332>3.0.CO;2-USearch in Google Scholar PubMed
[26] Yan WH, Lin A, Chen XJ, Dai MZ, Gan LH, Zhou MY, et al. Association of the maternal 14-bp insertion polymorphism in the HLA-G gene in women with recurrent spontaneous abortions. Tissue Antigens. 2006;68:521–3.10.1111/j.1399-0039.2006.00723.xSearch in Google Scholar PubMed
[27] Vianna P, Dalmáz CA, Veit TD, Tedoldi C, Roisenberg I, Chies JA. Immunogenetics of pregnancy: role of a 14-bp deletion in the maternal HLA-G gene in primiparous pre-eclamptic Brazilian women. Hum Immunol. 2007;68:668–74.10.1016/j.humimm.2007.05.006Search in Google Scholar PubMed
[28] Kaartokallio T, Cervera A, Kyllönen A, Laivuori K; FINNPEC Core Investigator Group. Gene expression profiling of pre-eclamptic placentae by RNA sequencing. Sci Rep. 2015;5:14107.10.1038/srep14107Search in Google Scholar PubMed
[29] Liang M, Niu J, Zhang L, Deng H, Ma J, Zhou W, et al. Gene expression profiling reveals different molecular patterns in G-protein coupled receptor signaling pathways between early- and late-onset preeclampsia. Placenta. 2016;40:52–9.10.1016/j.placenta.2016.02.015Search in Google Scholar PubMed
[30] Song J, Li Y, An RF. Identification of early-onset preeclampsia-related genes and microRNAs by bioinformatics approaches. Reprod Sci. 2015;22:954–63.10.1177/1933719115570898Search in Google Scholar PubMed
[31] Urrutia R. KRAB-containing zinc-finger repressor proteins. Genome Biol. 2003;4:231.10.1186/gb-2003-4-10-231Search in Google Scholar PubMed PubMed Central
[32] Evans RL, Pottala JV, Egland KA. Classifying patients for breast cancer by detection of autoantibodies against a panel of conformation-carrying antigens. Cancer Prev Res (Phila). 2014;7:545–55.10.1158/1940-6207.CAPR-13-0416Search in Google Scholar PubMed PubMed Central
[33] Turró S, Ingelmo-Torres M, Estanyol JM, Tebar F, Fernández MA, Albor CV, et al. Identification and characterization of associated with lipid droplet protein 1: A novel membrane-associated protein that resides on hepatic lipid droplets. Traffic. 2006;7:1254–69.10.1111/j.1600-0854.2006.00465.xSearch in Google Scholar PubMed
[34] Brown SH, Eather SR, Freeman DJ, Meyer BJ, Mitchell TW. A lipidomic analysis of placenta in preeclampsia: evidence for lipid storage. PLoS One. 2016;11:e0163972.10.1371/journal.pone.0163972Search in Google Scholar PubMed PubMed Central
[35] Carvalho G, Poalas K, Demian C, Hatchi E, Vazquez A, Bidère N. Participation of the cell polarity protein PALS1 to T-cell receptor-mediated NF-κB activation. PLoS One. 2011;6:e18159.10.1371/journal.pone.0018159Search in Google Scholar PubMed PubMed Central
[36] Brew O, Sullivan MH, Woodman A. Comparison of normal and pre-eclamptic placental gene expression: a systematic review with meta-analysis. PLoS One. 2016;11:e0161504.10.1371/journal.pone.0161504Search in Google Scholar PubMed PubMed Central
[37] Gay O, Nakamura F, Baudier J. Refilin holds the cap. Commun Integr Biol. 2011;4:791–5.10.4161/cib.17911Search in Google Scholar PubMed PubMed Central
[38] Pinto VI, Senini VW, Wang Y, Kazembe MP, McCulloch CA. Filamin A protects cells against force-induced apoptosis by stabilizing talin- and vinculin-containing cell adhesions. FASEB J. 2014;28:453–63.10.1096/fj.13-233759Search in Google Scholar PubMed
[39] Salaün C, Leroy C, Rousseau A, Boitez V, Beck L, Friedlander G. Identification of a novel transport-independent function of PiT1/SLC20A1 in the regulation of TNF-induced apoptosis. J Biol Chem. 2010;285:34408–18.10.1074/jbc.M110.130989Search in Google Scholar PubMed PubMed Central
[40] Beck L, Leroy C, Salaün C, Margall-Ducos G, Desdouets C, Friedlander G. Identification of a novel function of PiT1 critical for cell proliferation and independent of its phosphate transport activity. J Biol Chem. 2009;284:31363–74.10.1074/jbc.M109.053132Search in Google Scholar PubMed PubMed Central
[41] Gotsch F, Romero R, Friel L, Kusanovic JP, Espinoza J, Erez O, et al. CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia? J Matern Fetal Neonatal Med. 2007;20:777–92.10.1080/14767050701483298Search in Google Scholar PubMed PubMed Central
[42] Dallas PB, Gottardo NG, Firth MJ, Beesley AH, Hoffmann K, Terry PA, et al. Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR – how well do they correlate? BMC Genomics. 2005;6:59.10.1186/1471-2164-6-59Search in Google Scholar PubMed PubMed Central
Supplemental Material:
The online version of this article (DOI: https://doi.org/10.1515/jpm-2016-0406) offers supplementary material, available to authorized users.
©2017 Walter de Gruyter GmbH, Berlin/Boston
